1-(4,5-dimethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-5-methyl-1H-pyrazole-4-carboxylic acid, 95.0%, 250mg

6-BROMO-7-METHOXYQUINOLIN-4-OL, 95.0%, 5g

7-Bromo-5H-pyrido[4,3-b]indole, 95.0%, 250mg

Quinoxalin-2-amine, 95.0%, 100mg

4-ethoxy-3-{1-methyl-7-oxo-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-5-yl}benzene-1-sulfonyl chloride, 97%, 5g

3-Butyl-8-hydroxymethyl-7-propyl-3,7-dihydro-purine-2,6-dione, 100mg

2,4-Dichloro-5-cyanopyrimidine, 95.0%, 5g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 10 ml, 3500–5000 dalton(s), 12 Piece(s)

4-Ethylcyclohexanone, 95.0%, 500g

2-Fluorothiophenol, 98.0%, 25g

(2S,5S)-5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID, 95.0%, 100mg

1-Methylpiperidine-4-carboxylic acid, 95.0%, 100g

Methyl 3-(3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)-3-oxopropanoate, 97%, 1g